Skip to content
Life Sciences Series A Founded 2019

Satellite Bio

Developer of proprietary implantable satellite organs

📍 Cambridge, United States · Regenerative Medicine

Funding snapshot

Last roundSeries A
Amount$91M
Date25 February 2022

About

Developer of proprietary implantable satellite organs. The company is involved in cell therapy and regenerative medicine by using synthetic biology and tissue engineering for living therapeutic solutions. The company is also involved in the development of hydrogel grafts and develop in vitro assays.

Latest news

No articles yet.

Raising like Satellite Bio?

Analyze your pitch deck before your next raise.

Analyze My Deck →